The clinical observation which COPD with bulla on Salmeterol/fluticasone propionate

( views:1454, downloads:0 )
GAO Fu-sheng(The First People's Hospital of XingYang City,XingYang 450100,HeNan, China)
Journal Title:
Volume 04, Issue 12, 2010
10.3760/cma.j.issn 1673-8799.2010.12.53
Key Word:
Salmeterol/fluticasone propionate;Bulla;Chronic obstructive pulmonary disease

Abstract: Objective To approach the therapeutic effect of Salmeterol/fluticasone propionate on COPD with bulla. Methods Divides into 2 groups stochastically 120 example COPD patients, the control group uses the conventional treatment, the treatment group besides the conventional treatment, the inspiration Salmeterol/fluticasone propionate treats 12 months, observe the number of the increasing bullas and the original bulla. Results The treatment group sends the bulla cases of illness greatly not newly, original bulla does not have the change greatly, compares to the control group there were the significance difference. (P< 0. 05). Conclusion The inspiration Salmeterol/fluticasone propionate treats COPD to be possible to reduce the occurrence which the proliferating bulla, delays progress which the bulla.

  • [1]陆再英,钟南山.内科学.人民卫生出版社,2008:62-66.
  • [2]姚泰,吴博威.生理学.人民卫生出版社,2003:140-144.
  • [3]孙娴雯,李庆云,顾淑一,等.糖皮质激素治疗慢性阻塞性肺疾病的现状与展望.中华结核和呼吸杂志,2009,32:292-294.
  • [4]Tomic R,Lassiter CC,Ritzenthaler JD,et al.Ritzenthaler J,et al.Anti-Tissue Remodeling Effects of Corticosteroids:Fluticasone Propionate Inhibits Fibronectin Expression in Fibroblasts.Chest,Jan,2005,127:257-265.
  • [5]Celli BR,Thomas NE,Anderson JA,et al.Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease:results from the TORCH study.Am J Respir Crit Care Med,2008,178:332-338.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615